<?xml version="1.0" encoding="UTF-8"?>
<ref id="bjh15459-bib-0012">
 <mixed-citation publication-type="journal" id="bjh15459-cit-0012">
  <string-name>
   <surname>Morgan</surname>, 
   <given-names>G.J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Davies</surname>, 
   <given-names>F.E.</given-names>
  </string-name>, 
  <string-name>
   <surname>Gregory</surname>, 
   <given-names>W.M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Cocks</surname>, 
   <given-names>K.</given-names>
  </string-name>, 
  <string-name>
   <surname>Bell</surname>, 
   <given-names>S.E.</given-names>
  </string-name>, 
  <string-name>
   <surname>Szubert</surname>, 
   <given-names>A.J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Navarro‐Coy</surname>, 
   <given-names>N.</given-names>
  </string-name>, 
  <string-name>
   <surname>Drayson</surname>, 
   <given-names>M.T.</given-names>
  </string-name>, 
  <string-name>
   <surname>Owen</surname>, 
   <given-names>R.G.</given-names>
  </string-name>, 
  <string-name>
   <surname>Feyler</surname>, 
   <given-names>S.</given-names>
  </string-name>, 
  <string-name>
   <surname>Ashcroft</surname>, 
   <given-names>A.J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Ross</surname>, 
   <given-names>F.</given-names>
  </string-name>, 
  <string-name>
   <surname>Byrne</surname>, 
   <given-names>J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Roddie</surname>, 
   <given-names>H.</given-names>
  </string-name>, 
  <string-name>
   <surname>Rudin</surname>, 
   <given-names>C.</given-names>
  </string-name>, 
  <string-name>
   <surname>Cook</surname>, 
   <given-names>G.</given-names>
  </string-name>, 
  <string-name>
   <surname>Jackson</surname>, 
   <given-names>G.H.</given-names>
  </string-name> &amp; 
  <string-name>
   <surname>Child</surname>, 
   <given-names>J.A.</given-names>
  </string-name>; 
  <collab collab-type="authors">National Cancer Research Institute Haematological Oncology Clinical Study Group</collab> . (
  <year>2010</year>) 
  <article-title>First‐line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial</article-title>. 
  <source xml:lang="en">Lancet</source>, 
  <volume>376</volume>, 
  <fpage>1989</fpage>–
  <lpage>1999</lpage>.
  <pub-id pub-id-type="pmid">21131037</pub-id>
 </mixed-citation>
</ref>
